Omnicell, Inc. · NASDAQ:OMCL
Omnicell — Q4 2019 Earnings Presentation
7 slides from Omnicell's earnings presentation, Feb 6, 2020
Slide 1: 2019 Fourth Quarter and Full Year Earnings Call
™ a | oo ) r |) e e@a@EDpe GED @e D @ PD A2mpes e RD a» qa @ @ @e e VU Omnnicell, Inc. 2019 Fourth Quarter and Full Year February 6, 2020 Earnings Call
Slide 2: Safe Harbor Statement
Safe Harbor Statement To the extent any statements contained in this presentation deal with information that is not historical, these statements are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. As such, they are subject to the occurrence of
Slide 3: Purpose, Mission, Vision
Purpose There is a better way Mission Be the care provider's most trusted partner Vision Accelerate pharmacy to perfection
Slide 4: Central Pharmacy Clean Room
Central Pharmacy Clean Room 25,000 * 6% — 10% * errors annually in mean error rate in hospitals dispensing IV compounding 5M doses z 6 non-V dispensing errors 4. The Global Use of Medicine in 2019 and Outlook to 2023. January 2019). IQVIA INSTITUTE for Human Data Science. Gross spend estimate before
Slide 5: Profitable Organic Growth through Disciplined Execution
Profitable Organic Growth through Disciplined Execution geet. awe rere AGR Aner S pee Retail Point of Care entral Pharmac\ wes " eae $897 G e y Institutional, Payer million ( ) ~10% CAGR ~17% CAGR ~10% CAGR * Expansion + Prior Generation * Population Replacement Cycle Health Solutions * Prior Genera
Slide 6: Levers to Drive ~18% Non-GAAP Operating Margins
Levers to Drive ~18% Non-GAAP Operating Margins ~500 Bps leverage and benefits ~200 Bps investments and offsets ee ~18% Non-GAAP OM% ~15% + Economies of Scale + Innovation * Long Term Customer Partnerships * Customer Success + Manufacturing Savings + Infrastructure Investments + Process Improvements
Slide 7: Balancing Near Term Execution With Long Term Vision
Balancing Near Term Execution With Long Term Vision Revenue Operating Leverage Free Cash Flow ing Margin Goal © 2020 Omnicel, nc. Content is confidential and proprietary